Evidence map›Paper›PMID 29553507›Full record

ArticleJournal of visualized experiments : JoVE2018

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds.

Calliandra Maria de-Souza-Silva, Fernanda Guilhelmelli, Daniel Zamith-Miranda, Marco Antônio de Oliveira, Joshua Daniel Nosanchuk, Ildinete Silva-Pereira, Patrícia Albuquerque

Abstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Current medical mycology · 2025
    Article
  4. Article
  5. Identification and Antimicrobial Potential of Marine Sponges (International journal of microbiology · 2025
    Article
  6. Article
  7. Biogenic synthesis of silver nanoparticle byFrontiers in microbiology · 2024
    Article
  8. Article
  9. Article
  10. Life (Basel, Switzerland) · 2023
    Review
  11. Article
  12. AIMS microbiology · 2021
    Article
  13. Multi-omics Signature ofmSystems · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Calliandra Maria de-Souza-SilvaLaboratory of Molecular Biology, Department of Cellular Biology, Institute of Biological Sciences, University of Brasília.
Fernanda GuilhelmelliLaboratory of Molecular Biology, Department of Cellular Biology, Institute of Biological Sciences, University of Brasília.
Daniel Zamith-MirandaDepartment of Microbiology and Immunology, Albert Einstein College of Medicine; Division of Infectious Diseases, Department of Medicine, Albert Einstein College of Medicine.
Marco Antônio de OliveiraLaboratory of Molecular Biology, Department of Cellular Biology, Institute of Biological Sciences, University of Brasília.
Joshua Daniel NosanchukDepartment of Microbiology and Immunology, Albert Einstein College of Medicine; Division of Infectious Diseases, Department of Medicine, Albert Einstein College of Medicine.
Ildinete Silva-PereiraLaboratory of Molecular Biology, Department of Cellular Biology, Institute of Biological Sciences, University of Brasília; ildinetesp@gmail.com.
Patrícia AlbuquerqueLaboratory of Molecular Biology, Department of Cellular Biology, Institute of Biological Sciences, University of Brasília; Faculty of Ceilândia, University of Brasília; palbuquerque@unb.br.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fungal infections have become an important medical condition in the last decades, but the number of available antifungal drugs is limited. In this scenario, the search for new antifungal drugs is necessary. The protocol reported here details a method to screen peptides for their antifungal properties. It is based on the broth microdilution susceptibility test from the Clinical and Laboratory Standards Institute (CLSI) M27-A3 guidelines with modifications to suit the research of antimicrobial peptides as potential new antifungals. This protocol describes a functional assay to evaluate the activity of antifungal compounds and may be easily modified to suit any particular class of molecules under investigation. Since the assays are performed in 96-well plates using small volumes, a large-scale screening can be completed in a short amount of time, especially if carried out in an automation setting. This procedure illustrates how a standardized and adjustable clinical protocol can help the bench-work pursuit of new molecules to improve the therapy of fungal diseases.

Indexed as

Antifungal AgentsMicrobial Sensitivity TestsAntifungal Agents

Identifiers

PMID29553507
PMCPMC5912413

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.